Strength
60 mg/1
Manufacturer
Neurocrine Biosciences, Inc.NDC
70370106001
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
10/1/2025
Active Ingredients
VALBENAZINE TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA209241On Market Since
4/23/2021
Pharmacological Classes
Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.